Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 02, 2026
Why Is SMX (Security Matters) Public Limited Company (SMX) Stock Down -25.32% Today?

Why Is SMX (Security Matters) Public Limited Company (SMX) Stock Down -25.32% Today?

Key Takeaways

  • Shares plunged 25.32% in mid-morning trading, falling from a prior close of $6.16 to roughly $4.60.
  • The decline reversed an after-hours spike of more than 38% that followed a burst of company-issued promotional releases on its "trueGold" and "Made in America" technology.
  • Structural concerns—chronic dilution, repeated reverse stock splits, and a going-concern warning—continue to weigh on sentiment.
  • The move was company-specific, sharply diverging from a broadly flat Nasdaq and its industrial peer group.
  • Traders are watching whether the stock can hold new 52-week lows and how management addresses ongoing Nasdaq listing-compliance and funding risks.

Opening Summary

SMX (Security Matters) Public Limited Company, an Ireland-based provider of brand protection, authentication, and track-and-trace technology, saw its shares sell off sharply during Friday's session. The company's proprietary molecular-marker system, paired with a blockchain-based digital platform, is designed to give physical materials a verifiable digital identity. On Thursday, the stock closed at $6.16, and by mid-morning Friday it was changing hands around $4.60—a decline of $1.56, or 25.32%—confirming a decisive move to the downside. The immediate catalyst cited by markets was the rapid unwinding of an overnight speculative rally that had briefly sent the shares higher after the close.

After-Hours Rally Fades, Sparking Sharp Reversal

The session's weakness followed a brief, dramatic pop in extended trading. On Thursday evening, SMX shares surged more than 38% in after-hours activity after a series of company press releases highlighted its "trueGold" platform—which embeds an invisible molecular marker in gold—and its ability to verify "Made in America" supply-chain claims. The announcements leaned into investor interest in physical gold and onshoring, but the buying momentum did not carry into the regular session.

Instead, the after-hours gains were entirely erased within the first minutes of Friday's open, and selling accelerated from there. For a micro-cap name trading on limited liquidity, overnight pops that lack fresh fundamental backing often reverse quickly as profit-taking and momentum-chasing give way to the stock's longer-term downtrend. That dynamic played out in full, with the shares sliding to fresh 52-week lows during morning trading.

Structural Pressures: Dilution, Reverse Splits and Going-Concern Risk

Beyond the immediate price action, SMX carries an unusually heavy structural overhang that has kept sellers in control for months. The company has executed a long series of reverse stock splits since 2024—most recently a 20-for-1 split in May 2026 followed by a 2.285-for-1 split in June 2026—as management works to maintain Nasdaq's minimum bid-price requirement. The shares have also been pressured by persistent equity dilution, including convertible-note conversions and expanded executive incentive-equity grants, which investors view as a direct threat to existing holders.

Compounding the problem, the company's independent auditor has issued a going-concern warning, citing recurring losses, negative operating cash flow, and reliance on external financing. Accumulated losses stood at roughly $251 million at the end of 2025, against a market capitalization of only about $6.7 million. With no analyst coverage and no meaningful revenue base to offset a heavy cash burn, the stock has repeatedly struggled to hold any rally.

Market Context and Trading Activity

The sell-off in SMX was notably detached from the broader tape. Major U.S. indices were essentially flat to modestly lower during the morning, and there was no sector-wide catalyst weighing on industrial or specialty business-services names. This divergence underscores that the move was driven by stock-specific factors rather than a macro or sector rotation.

Trading activity was elevated relative to the thinly traded average for the name, consistent with the reversal of the overnight spike and the breaking of technical levels. The shares traded well below their 50-day and 200-day moving averages, and the decline took the stock through the prior session's low to set a fresh 52-week low. Momentum indicators had already signaled deep oversold conditions before Friday's drop, yet the absence of fundamental support has repeatedly limited the effectiveness of any technical bounce.

What Comes Next for SMX

Investors will be watching several factors closely in the weeks ahead. The company's next earnings update is expected in mid-October, and its ability to demonstrate progress toward commercialization, revenue generation, and a path to breakeven will be central to any stabilization in sentiment. Equally important is how management addresses Nasdaq listing-compliance risk and whether further capital raises—and the dilution that accompanies them—become necessary.

Risks remain substantial. The stock's extended decline, repeated reverse splits, going-concern disclosure, and thin float all contribute to extreme volatility in both directions. While promotional activity around the company's technology has occasionally triggered sharp short-term pops, those moves have so far failed to hold without corresponding improvements in the underlying business.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are highlighted in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving users a way to explore data-driven approaches across different market environments. To see which automated strategies are currently leading, visit the Trending AI Robots page today.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SMX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SMX's RSI Indicator remains in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +7.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMX advanced for three days, in 78 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

SMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMX as a result. In 58 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for SMX turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In 21 of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

SMX moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SMX crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SMX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.165) is normal, around the industry mean (8.137). P/E Ratio (0.021) is within average values for comparable stocks, (60.108). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (9.694).

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. SMX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 7.06B. The market cap for tickers in the group ranges from 47.27K to 80.14B. CTAS holds the highest valuation in this group at 80.14B. The lowest valued company is KUBR at 47.27K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -3%. DLHC experienced the highest price growth at 18%, while SMX experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was 13% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 53
Price Growth Rating: 61
SMR Rating: 73
Profit Risk Rating: 85
Seasonality Score: 28 (-100 ... +100)
View a ticker or compare two or three
SMX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry OfficeEquipmentSupplies

Industry
N/A
Address
Sussex Road
Phone
+353 19201000
Employees
19
Web
https://smx.tech/home
Interact to see
Advertisement
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
WDC shares surged approximately +10% in Wednesday's session, advancing to approximately $296–$297 from a prior close near $269.82 on March 31, 2026. The primary catalyst is a major analyst upgrade: Bernstein raised its rating on Western Digital from Market Perform to Outperform and dramatically doubled its price target to $340 from $170.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.